METASTATIC THYROID GLAND CARCINOMA
Clinical trials for METASTATIC THYROID GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC THYROID GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC THYROID GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to tame aggressive thyroid cancer
Disease control OngoingThis study is testing whether two drugs, lenvatinib and pembrolizumab, work better together for people with advanced anaplastic thyroid cancer that cannot be removed by surgery or has spread. Lenvatinib aims to block tumor growth, while pembrolizumab helps the body's immune syste…
Matched conditions: METASTATIC THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo trial offers hope for Tough-to-Treat thyroid cancer
Disease control OngoingThis study is testing whether two targeted cancer drugs (encorafenib and binimetinib), given with or without an immunotherapy drug (nivolumab), can help control advanced thyroid cancer that has a specific genetic change (BRAF V600 mutation) and has stopped responding to standard …
Matched conditions: METASTATIC THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test new drug duo against tough thyroid cancers
Disease control OngoingThis early-stage study is testing the safety and best dose of a two-drug combination (dabrafenib and lapatinib) for adults with advanced thyroid cancer that has a specific genetic change (BRAF mutation) and has stopped responding to standard treatments. The main goal is to see ho…
Matched conditions: METASTATIC THYROID GLAND CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for fighting rare, Fast-Growing thyroid cancer
Disease control OngoingThis study is testing whether combining a drug that helps the immune system fight cancer (atezolizumab) with different chemotherapy drugs can help people with aggressive forms of thyroid cancer that have spread or cannot be removed by surgery. The goal is to see if this combinati…
Matched conditions: METASTATIC THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug combo aims to Re-Sensitize tough thyroid cancers to standard treatment
Disease control OngoingThis study is testing if adding an oral drug called trametinib can make radioactive iodine treatment work again for people with advanced thyroid cancer that has spread or come back and no longer responds to iodine. The goal is to see if trametinib helps the cancer absorb more iod…
Matched conditions: METASTATIC THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC